🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.50
-0.90 (-3.17%)
Nov 20, 2026, 1:30 PM CST

TPEX:4111 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
397.85443.91336.19381.05456.25252.27
Cash & Short-Term Investments
397.85443.91336.19381.05456.25252.27
Cash Growth
-5.69%32.04%-11.77%-16.48%80.86%-24.88%
Accounts Receivable
345.71352.14326.5309.71282.64281.4
Other Receivables
7.636.2318.5819.940.660.81
Receivables
353.34358.37345.07329.65283.3282.2
Inventory
108.95103.3896.8589.1799.0390.25
Prepaid Expenses
10.848.056.494.112.239.92
Other Current Assets
35.5311.410.020.0216.8216.83
Total Current Assets
906.5925.12784.62804857.64651.47
Property, Plant & Equipment
877.02764.99756.98720.35785.33899.42
Long-Term Investments
2.421.811.811.843.483.97
Other Intangible Assets
0.871.411.631.461.040.9
Long-Term Deferred Tax Assets
2.856.6111.2335.5454.26.1
Other Long-Term Assets
228.06237.84193.37202.9298.8497.92
Total Assets
2,0181,9381,7501,7661,8011,660

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
248.44223.41240.28226.33237.03205.74
Short-Term Debt
101010120120130
Current Portion of Leases
3.437.479.532.126.116.72
Current Income Taxes Payable
18.4639.111.218.714.01
Current Unearned Revenue
3.40.010.141.174.777.79
Other Current Liabilities
198.02181.01111.85100.6395.2982.63
Total Current Liabilities
481.74461372.8451.46481.89446.88
Long-Term Leases
3.986.437.090.782.287.28
Pension & Post-Retirement Benefits
--8.8911.249.0818.61
Long-Term Deferred Tax Liabilities
77.9678.6779.9476.5277.8576.52
Other Long-Term Liabilities
10.4110.956.357.057.299.75
Total Liabilities
574.09557.04475.08547.04578.38559.04

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
598.32598.32569.83569.83569.83569.83
Additional Paid-In Capital
48.8548.8548.8548.8548.8548.85
Retained Earnings
799.17736.4658.71603.19604.63506.39
Comprehensive Income & Other
-2.72-2.84-2.84-2.8-1.16-24.33
Shareholders' Equity
1,4441,3811,2751,2191,2221,101
Total Liabilities & Equity
2,0181,9381,7501,7661,8011,660

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
17.4123.926.62122.9128.38144
Net Cash (Debt)
380.44420.01309.57258.15327.87108.27
Net Cash Growth
-4.01%35.68%19.92%-21.26%202.84%-66.51%
Net Cash Per Share
6.276.955.154.305.451.80
Filing Date Shares Outstanding
59.5359.4659.8359.8359.8359.83
Total Common Shares Outstanding
59.5359.4659.8359.8359.8359.83
Working Capital
424.75464.12411.82352.54375.74204.59
Book Value Per Share
24.2523.2221.3020.3720.4318.40
Tangible Book Value
1,4431,3791,2731,2181,2211,100
Tangible Book Value Per Share
24.2323.2021.2720.3520.4118.38
Land
--371.9371.9478.28478.28
Buildings
--662.04636.77538.78703.06
Machinery
--585.74549.8529.11569.08
Construction In Progress
--36.2830.5182.482.96
Leasehold Improvements
--2.442.293.413.41